PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-50

  1. 2,756 Posts.
    lightbulb Created with Sketch. 274
    More information required ... the previous announcement was the FDA requesting modifications to the adrenal screening and mitigation plan.

    What further information would be required now? All the cards are on the table. Back and forths have been done already. PAR said they would adopt FDAs modifications and responded back within a week.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.